Open AccessPARP Inhibitor Shows Promise as Pancreatic Cancer Maintenance Therapy
Author(s) -
Kurt Samson
Publication year - 2019
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000559651.06734.06
Subject(s) - medicine , pancreatic cancer , oncology , parp inhibitor , cancer , clinical trial , interim analysis , population , adverse effect , olaparib , chemotherapy , hematology , interim , poly adp ribose polymerase , biochemistry , chemistry , polymerase , gene , history , environmental health , archaeology